GAITHERSBURG, Md., January 26, 2021 — GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today launched several new genetic tests, including repeat expansion analysis for spinocerebellar ataxia (SCA), Friedreich ataxia, and other common forms of hereditary ataxias. With these additions, GeneDx has created a comprehensive and affordable offering that covers the […]
Author Archives: Erika Erdmann
BioReference executes COVID-19 testing program for NBA and NHL for 2020-21 seasons, as well as U.S. Women’s and Men’s National Soccer Teams, Winter X Games and NBA G League ELMWOOD PARK, N.J., January 26, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced COVID-19 testing agreements for players and officials, as well […]
How aware are you of the small but powerful butterfly-shaped glad that resides at the base of your neck? January is Thyroid Awareness Month, a time to share about the importance of this gland and draw attention to symptoms that may be related to thyroid disease. Although the thyroid gland is small, it produces a […]
Scarlet brings diagnostic service to patients’ homes, offices and other preferred locations, delivering an on-demand, safe and convenient diagnostic experience for patients and healthcare providers ELMWOOD PARK, N.J., January 13, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today introduced Scarlet Health™, an in-home, fully integrated digital platform providing access to on-demand diagnostic […]
Seahawks The “Seahawks Swab Team” is a big reason why the 2020 season was even possible, and they’re being honored for their extremely dedicated work testing players and staff day in and day out at the VMAC. All season long, the honor of raising the 12 Flag has gone to people and organizations who have […]
January is Cervical Cancer Awareness Month and a reminder that the most important thing you can do to prevent cervical cancer is to start screening at the age of 21. The American Cancer Society estimated that about 13,800 new cases of invasive cervical cancer would be diagnosed and about 4,290 women would die in the […]
Nearly 210,000 New York City students, teachers, principals and staff were tested by BioReference with a positivity rate of 0.47% ELMWOOD PARK, N.J., (January 4, 2021) – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR tests for public schools throughout New York City’s boroughs, with a positivity rate of […]
The Bills leverage testing capabilities from NFL testing provider, BioReference, to initiate fan testing program ORCHARD PARK, N.Y., December 31, 2020 – Buffalo Bills, 2020 AFC East Division Champions, and BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced they will be performing fan testing for the AFC Divisional Wild Card playoff game at […]
This past year has been one of uncertainty and many people’s lives have changed drastically over the course of nine months. While maintaining social distancing and stay at home orders, routine health has taken a back seat to protecting ourselves and each other from infection. As we wrap up the holidays and enter into a […]
With the introduction of my·labology earlier this year, BioReference put the power of health back into your hands and made requesting tests easier than ever. At www.mylabology.com, patients can request* a test, then visit a patient service center and get test results securely back to a mobile device. What is my·labology? Since 1981, we have […]